InvestorsHub Logo
Followers 19
Posts 2315
Boards Moderated 0
Alias Born 03/12/2013

Re: dcspka post# 26457

Friday, 11/28/2014 10:11:22 PM

Friday, November 28, 2014 10:11:22 PM

Post# of 30046
Silence of The Lambs You Understand..
Three months after the Patent pending was assigned to Provista Diagnostics..This is what happened next..The agreement between AMDL Diagnostics Inc. and Uni-Pharma..As you can see..AMDL Diagnostics Inc. is a going concern according to Delaware Corporation Commission..So the agreement is still in force...The LC Sentinel Lung and Breast Cancer Test is one of the same utilizing DR-70 and a combination of Bio-Markers from Arizona State University as our Underdawg hero stated in his blog last year..Thank you for the insights Garza...Wolf

On June 6th 2013, we entered into a 5-year license agreement between AMDL Diagnostics, Inc. (“ADI”), a division within our company, and Uni Pharma Co., Ltd. a Taipei Taiwan limited liability company (“UNI”) that provides UNI with a 5-year exclusive license (subject to automatic renewal for an additional 5 years) to RXPC’s Onko-Sure® (formerly called DR-70 cancer blood test kits (the “Tests”), procedures, analyses, data, know how, manufacturing, manufacturing processes, components, trademarks and intellectual property.


http://www.sec.gov/Archives/edgar/data/838879/000121390013003078/f8k061113_radientpharm.htm

"If we become the party to any type of bankruptcy action or proceeding that disrupts our business and ability to deliver the Tests, UNI has the right to use, market and sell the Tests and carry out any tasks to do same; provided however, sales made by UNI pursuant thereto, remain subject to the payment of royalty fees."







dcspka Friday, 11/28/14 09:30:10 PM
Re: guardiangel post# 26456
Post # of 26457
So lets see:

The only product that William is actively promoting is the Lung Cancer Test (using DR-70). The only patent that William would have pending (that he would be discussing in his presentation) would center around DR-70/ Lung Cancer Test.

And we know this patent pending is assigned to Provista. Therefore William, Provista, Radient, and DR-70 are all tied together.

As Long Investors always have known.


***************************************************************

http://seekingalpha.com/user/8702411/instablog


The Many Veils Of Radient Pharmaceuticals (Onko-Sure DR-70)

I will provide a more storied version of this article, but for now here are some links to contemplate you understand.

Equivilant to Radient's CIT Technology:

$500 million dollar buyout!

Guess which one of these companies are involved with Radient behind the scenes?

Arizona State University, Mayo Clinic, Mayo Collaborative Services, etc...

What's going on in Arizona?

ASU Spinout HealthTell Raises $4 million in New Funding for Innovative Cancer Tests

Just a quick tidbit for now. Stay tuned to see how Radient Pharmaceuticals is controlling the Global Cancer Diagnostics market behind the scenes, and what the few remaining shareholders will get as a cash distribution / shares of the new company from the upcoming merger!
Tags: RXPC, rumored

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.